Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score

BACKGROUND: Vietnam and Saudi Arabia have high disease burden of primary hepatocellular carcinoma (HCC). Early detection in asymptomatic patients at risk for HCC is a strategy to improve survival outcomes in HCC management. GALAD score, a serum-based panel, has demonstrated promising clinical utilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Thai Ngoc, Pham, Trang Ngoc Doan, Hoang, Long Bao, Nguyen, Van Thi, Dao, Hang Viet, Dao, Diem Vu Bich, Alessy, Saleh, Pham, Hien Ba, Pham, Thuy Thi Thu, Nguyen, Linh Duc Duy, Nguyen, Khue, Abaalkhail, Faisal, Manal, Mohammed, Mawardi, Mohammad, AlZahrani, May, Alswat, Khalid, Alghamdi, Hamdan, Sanai, Faisal M., Siddiqui, Mohammed Amir, Nguyen, Nam Hai, Vaidya, Dhananjay, Phan, Hai Thanh, Johnson, Philip J., Alqahtani, Saleh A., Dao, Doan Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506187/
https://www.ncbi.nlm.nih.gov/pubmed/37723439
http://dx.doi.org/10.1186/s12885-023-11167-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506187/
https://www.ncbi.nlm.nih.gov/pubmed/37723439
http://dx.doi.org/10.1186/s12885-023-11167-9

Ejemplares similares